Checked.be
Active
BE 0445.650.266Private limited company
PHYSIOSTÉA
Rue Bourlon(Bassil) 48 ·7830 Silly, Belgium· 34 yrs active
Sector: Physiotherapy
(86951)
Conclusion
PHYSIOSTÉA has been active since 1991 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €5k and a net result of €6k. Equity is growing by ~251.3% per year across the filed fiscal years. Its solvency ranks better than 58% of 1258 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Based on the State Gazette, CBE and 3 annual accounts.
Key figures
| Equity | €5k |
| Net result | €6k |
| Better than sector | 58% |
| Active | 34 yrs |
Financial profile
94
/ 100
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Health
100
Profitability
87
Solvency
99
Growth
85
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Long-established
Founded in 1991, 34 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
100
/ 100
Excellent
Computed from 6 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€500
estimate, not credit advice
Score history
5
2022
17
2023
100
2024
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 2.23 (≥ 1.5)
+10
Quick ratio
Quick ratio 2.23 (≥ 1.0)
+5
Leverage
Debt/equity 0.60 (< 1.0)
+10
Profitability
ROE 123% (≥ 10%)
+10
EBITDA margin
EBITDA-marge 14% (≥ 10%)
+8
Interest coverage
Interest coverage 73.7× (≥ 3×)
+8
Profit trend
Net profit up YoY
+5
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Financial overview
Annual accounts filed on 27-11-2025 with the NBB · fiscal year 2024 · full schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~251.3%/year over 3 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2024 · NACE 86, Human health activities · compared within the same schema type (full schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 62.5% | 55.2% | |
| Net result | €6k | €71k | |
| Equity | €5k | €317k | |
| Gross operating margin | €7k | €290k | |
| Total assets | €8k | €774k |
€48k
+7320.6%
22-24
€7k
-
22-24
€6k
-
22-24
€6k
-
22-24
€8k
+1078.7%
22-24
€5k
-
22-24
€4k
-
22-24
€155
-
22-24
€3k
+66.3%
22-24
€3k
+66.3%
22-24
2.23
+492.6%
22-24
2.23
+492.6%
22-24
62.5%
-
22-24
0.60
-
22-24
122.6%
+203.3%
22-24
76.6%
-
22-24
13.1%
-
22-24
13.9%
-
22-24
73.68
-
22-24
Figures by fiscal year and ratios
| Fiscal year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Deposit | full schema | full schema | full schema |
| Revenue | €48k | €650 | - |
| EBITDA | €7k | - | - |
| Net profit | €6k | €-470 | €2k |
| Cash flow | €6k | - | - |
| Staff costs | - | - | - |
| Income taxes | €155 | - | - |
| Dividends | - | - | - |
| Total assets | €8k | €700 | €1k |
| Equity | €5k | €-1k | €-693 |
| Debt | €3k | €2k | €2k |
| of which ≤ 1y | €3k | €2k | €2k |
| of which > 1y | - | - | - |
| Working capital | €4k | €-1k | €-693 |
| Employees (FTE) | - | - | - |
Ratios (computed)
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Current ratio | 2.23 | 0.38 | 0.68 |
| Quick ratio | 2.23 | 0.38 | 0.68 |
| Working capital ratio | 46.1% | -166.1% | -46.9% |
| Solvency | 62.5% | -166.1% | -46.9% |
| Debt / equity | 0.60 | -1.60 | -3.13 |
| Long-term debt ratio | - | - | - |
| Interest coverage | 73.68 | - | - |
| Gross margin | 14.1% | -65.2% | - |
| Net margin | 13.1% | -72.3% | - |
| ROA | 76.6% | -67.1% | 101.7% |
| ROE | 122.6% | 40.4% | -217.0% |
| EBITDA margin | 13.9% | - | - |
| Days sales outstanding | 35d | 354d | - |
| Days payable outstanding | - | - | - |
| Inventory turnover | - | - | - |
| Days inventory (DSI) | - | - | - |
Balance-sheet composition 2024
Full annual accounts (22 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Balance sheet, Assets | ||||
| TOTAL ASSETS | 20/58 | €8k | €700 | €1k |
| Fixed assets | 21/28 | €1k | - | - |
| Tangible fixed assets | 22/27 | €1k | - | - |
| Current assets | 29/58 | €7k | €700 | €1k |
| Amounts receivable within one year | 40/41 | €5k | €630 | €1k |
| Cash & bank | 54/58 | €2k | €70 | €399 |
| Balance sheet, Equity & liabilities | ||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €8k | €700 | €1k |
| Equity | 10/15 | €5k | €-1k | €-693 |
| Contributions / capital | 10/11 | €6k | €6k | €6k |
| Reserves | 13 | €1k | €1k | €1k |
| Accumulated profits (losses) | 14 | €-2k | €-9k | €-8k |
| Amounts payable | 17/49 | €3k | €2k | €2k |
| Amounts payable within one year | 42/48 | €3k | €2k | €2k |
| Trade debts payable within one year | 44 | - | - | €359 |
| Income statement | ||||
| Turnover | 70 | €48k | €650 | - |
| Gross operating margin | 9900 | €7k | €-424 | €2k |
| Operating result | 9901 | €7k | €-424 | €2k |
| Financial charges | 65 | €91 | €46 | €49 |
| Result before taxes | 9903 | €6k | €-470 | €2k |
| Income taxes | 67/77 | €155 | - | - |
| Net result for the period | 9904 | €6k | €-470 | €2k |
| Result to be appropriated | 9905 | €6k | €-470 | €2k |
Directors & mandates
Current directors & mandates
-
Léa Renée RAMPELBERGAdministrateur non statutaireState Gazette act 24365671 (23-02-2024)Current23-02-2024 → present
Former directors (1)
-
Karine LEBEGGEDirectorState Gazette act 24365671 (23-02-2024)Former- → 23-02-2024
Legal Structure
| NACE primary | Physiotherapy(86951) |
| Legal form | Private limited company(610) |
| Incorporation | 17-10-1991 |
| Status | Active |
| Postal code | 7830 |
Real-estate footprint
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 55001C0290/00K000 | Wallonia | 1,685 m² | 1 · 165 m² | 7.2 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
2025
27-11
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 119 days late
2024
31-12
Financial
Back to profitnet €6k
Net result €6k after one loss-making year.
31-12
Financial
Liquidity times 6current ratio 2.23
Current ratio from 0.38 to 2.23.
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 29 days late
23-02
State Gazette act
Director changes
v3.2
2023
31-12
Financial
Weakest financial yearnet €-470 ▼131%
Net result drops to €-470, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 30 days late
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 30 days late
2021
29-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 29 days late
2020
06-11
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 98 days late
2018
26-09
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 57 days late
2017
05-09
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 36 days late
2015
26-08
NBB filing
Annual accounts filed
fiscal year 2014 · full schema · 26 days late
2014
07-07
NBB filing
Annual accounts filed
fiscal year 2013 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Belgisch Staatsblad, acts
All acts · 1
updated 2 years ago
2024
23-02-2024 1 director appointed, 1 resigning
- Léa Renée RAMPELBERG, Administrateur non statutaire
- Karine LEBEGGE, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Karine LEBEGGE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur non statutaire",
"person": {
"rrn": null,
"name": "L\u00E9a Ren\u00E9e RAMPELBERG",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0445.650.266",
"name_full": "PHYSIOST\u00C9A"
}
}Credit advice
Company registry (CBE)
Activities
Human health activities86905Physiotherapy86951
Names & trade names
| Legal nameFR | PHYSIOSTÉA |
Similar companies
DKINEO
BE 0778.674.230 · Sint-Jans-Molenbeek
ALTER NATIVE
BE 0738.531.769 · Esneux
Osteopathie Jason Pierloot
BE 1010.096.434 · Haacht
Podologie Symoens
BE 0753.660.603 · Lokeren
Studio FC
BE 1014.816.275 · Zemst